The Food and Drug Administration (FDA) has approved the first over-the-counter continuous glucose monitor (CGM) indicated for children aged 2 years and older who do not use insulin, according to an agency news release. The wearable device continuously measures glucose levels and displays readings and trends through a smartphone application, which can be used on a caregiver’s device. Real-time glucose data—measured every 15 minutes—is intended to help children and their parents better understand the effects …
Read More